Results 291 to 300 of about 9,409,354 (304)

Identification of dysregulated gene clusters and pathways driving ocular surface squamous neoplasia progression. [PDF]

open access: yesSci Rep
Goel K   +10 more
europepmc   +1 more source

Autoimmune Diseases of the Eyelid Skin: Molecular Pathways, Clinical Manifestations, and Therapeutic Insights. [PDF]

open access: yesInt J Mol Sci
Luboń W   +4 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders

Journal of Ocular Pharmacology and Therapeutics, 2023
Losartan is an angiotensin II receptor blocker (ARB) that impedes transforming growth factor (TGF) beta signaling by inhibiting activation of signal transduction molecule extracellular signal-regulated kinase (ERK).
S. Wilson
semanticscholar   +1 more source

[Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study].

Klinische Monatsblätter für Augenheilkunde, 2002
T. Reinhard   +5 more
semanticscholar   +1 more source

Conjunctival Melanoma: Current Treatments and Future Options

American Journal of Clinical Dermatology, 2020
Joseph M. Grimes   +4 more
semanticscholar   +1 more source

Tear osteopontin levels in patients with allergic conjunctival diseases

Graefe's Archive for Clinical and Experimental Ophthalmology, 2002
E. Uchio   +4 more
semanticscholar   +1 more source

Penetrating keratoplasty in cicatrizing conjunctival diseases.

Ophthalmology (Rochester, Minn.), 1995
Iknur Tugal-Tutkun, Y. Akova, C. Foster
semanticscholar   +1 more source

Impression cytology with transfer in xerophtalmia and conjunctival diseases

International ophtalmology, 1992
S. Resnikoff   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy